
Vitamin C Trial in Precancerous Blood Conditions Misses Its Main Goal
Daily vitamin C did not slow the growth of abnormal blood cell clones in people with precancerous blood conditions or early-stage blood cancers, the EVITA trial reported in the journal Cancer. Its…










